Body composition changes and predictors of lipodystrophy in a cohort of pre-pubertal HIV-infected children.
暂无分享,去创建一个
C. Palchetti | V. Szejnfeld | R. Patin | R. C. Succi | P. F. Teixeira | A. Barbosa | F. Oliveira | R. Succi
[1] R. Haubrich,et al. Biceps Skin-fold Thickness May Detect and Predict Early Lipoatrophy in HIV-infected Children , 2013, The Pediatric infectious disease journal.
[2] C. Palchetti,et al. Body composition and lipodystrophy in prepubertal HIV-infected children , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[3] G. McComsey,et al. Metabolic complications and treatment of perinatally HIV-infected children and adolescents , 2013, Journal of the International AIDS Society.
[4] L. Kuhn,et al. Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy , 2012, Archives of Disease in Childhood.
[5] R. A. Rascón-Pacheco,et al. Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents. , 2012, European journal of endocrinology.
[6] W. Borkowsky,et al. Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study. , 2011, The American journal of clinical nutrition.
[7] Ò. Miró,et al. Mitochondrial Impact of Human Immunodeficiency Virus and Antiretrovirals on Infected Pediatric Patients With or Without Lipodystrophy , 2011, The Pediatric infectious disease journal.
[8] W. Borkowsky,et al. Factors Associated with Insulin Resistance among Children and Adolescents Perinatally Infected with HIV-1 in the Pediatric HIV/AIDS Cohort Study , 2011, Hormone Research in Paediatrics.
[9] M. Muñoz-Fernández,et al. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome. , 2011, The Journal of infection.
[10] M. Theodoridou,et al. Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy , 2011, Hormones.
[11] A. Fernandes,et al. Lipodystrophy, lipid profile changes, and low serum retinol and carotenoid levels in children and adolescents with acquired immunodeficiency syndrome. , 2010, Nutrition.
[12] T. Miller. The next decade: cardiovascular risks, outcomes, prevention, and treatment in pediatric HIV infection. , 2010, Jornal de pediatria.
[13] Marcos V. Pone,et al. Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy. , 2010, Jornal de pediatria.
[14] R. Shafer. The challenge of antiretroviral drug resistance in HIV-1-infected children. , 2009, Jornal de pediatria.
[15] R. Parker,et al. The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications , 2009, Toxicologic pathology.
[16] Jens C. Krause,et al. Metabolic Abnormalities in Human Immunodeficiency Virus-Infected Children: Two-Year Follow-up , 2009, Journal of pediatric endocrinology & metabolism : JPEM.
[17] A. Franzese,et al. Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children? , 2008, Journal of endocrinological investigation.
[18] M. Sormani,et al. Evaluation of insulin resistance in a cohort of HIV-infected youth. , 2007, European journal of endocrinology.
[19] R. Rutstein,et al. Hypoadiponectinemia, Dyslipidemia, and Impaired Growth in Children with HIV-associated Facial Lipoatrophy , 2007, Journal of pediatric endocrinology & metabolism : JPEM.
[20] M. J. García-Miguel,et al. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children , 2005, European Journal of Pediatrics.
[21] P. Brambilla,et al. Increased Lipodystrophy Is Associated With Increased Exposure to Highly Active Antiretroviral Therapy in HIV-Infected Children , 2003, Journal of acquired immune deficiency syndromes.
[22] P. Brambilla,et al. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy , 2001, AIDS.
[23] M. Polak,et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children , 2000, AIDS.
[24] D. Cooper,et al. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance , 1998, The Lancet.
[25] C. Bloch,et al. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. , 1995, The Journal of clinical endocrinology and metabolism.
[26] W. A. Marshall,et al. Growth and physiological development during adolescence. , 1968, Annual review of medicine.